The settlement highlights the lasting risks of exposing genetic data that can’t be changed or replaced.

Add Yahoo as a preferred source to see more of our stories on Google. 23andMe headquarters in Sunnyvale, Calif. (Tayfun Coskun/Anadolu via Getty Images) Today is the deadline for customers of the ...

The sale of 23andMe was finalized this week, following the company filing for bankruptcy in March. The sale was previously approved by a judge. The company was purchased by the nonprofit TTAM Research ...

The Remote Viewing Program probed whether people could use extrasensory perception to conduct recon.

23andMe co-founder and former CEO Anne Wojcicki has agreed to repurchase the bankrupt genetics firm for $305 million, after her nonprofit outbid pharmaceutical giant Regeneron in a court-supervised ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min 23andMe bought high — as Covid ...

With a purchase price of $256 million, some investors might think the valuation is a bit rich for a business in such a dire position as 23andMe, but it won't put a huge dent into Regeneron's ...

Anne Wojcicki's winning bid to reclaim control of 23andMe (MEHCQ) doesn't necessarily end the fight over what happens to the DNA of 15 million people collected by the bankrupt consumer genomics ...

The bidding competition over 23andMe may not be over. The founder of 23andMe, Anne Wojcicki, has asked a federal bankruptcy court judge to reopen an auction for the genetic testing company, saying she ...

My first week at 23andMe, the Wall Street Journal declared the company was worth “nearly $0.” By the time I left, a little more than a year later, the company had filed for bankruptcy. As a ...

A court hearing to consider the transaction’s approval is scheduled for June 17, according to 23andMe Abigail Adams is a Human Interest Writer-Reporter for PEOPLE. Justin Sullivan/Getty; Michael Nagle ...

Bankrupt 23andMe is facing a lawsuit over its plans to sell customer genetic information. Twenty-seven states and the District of Columbia took legal action this week against 23andMe in the U.S.